• Je něco špatně v tomto záznamu ?

Primary prevention efforts are poorly developed in people at high cardiovascular risk: A report from the European Society of Cardiology EURObservational Research Programme EUROASPIRE V survey in 16 European countries

K. Kotseva, G. De Backer, D. De Bacquer, L. Rydén, A. Hoes, D. Grobbee, A. Maggioni, P. Marques-Vidal, C. Jennings, A. Abreu, C. Aguiar, J. Badariene, J. Bruthans, R. Cifkova, K. Davletov, M. Dilic, M. Dolzhenko, D. Gaita, N. Gotcheva, H....

. 2021 ; 28 (4) : 370-379. [pub] 20210508

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc22004359

BACKGROUND: European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EUROASPIRE) V in primary care was carried out by the European Society of Cardiology EURObservational Research Programme in 2016-2018. The main objective was to determine whether the 2016 Joint European Societies' guidelines on cardiovascular disease prevention in people at high cardiovascular risk have been implemented in clinical practice. METHODS: The method used was a cross-stional survey in 78 centres from 16 European countries. Patients without a history of atherosclerotic cardiovascular disease either started on blood pressure and/or lipid and/or glucose lowering treatments were identified and interviewed ≥ 6 months after the start of medication. RESULTS: A total of 3562 medical records were reviewed and 2759 patients (57.6% women; mean age 59.0 ± 11.6 years) interviewed (interview rate 70.0%). The risk factor control was poor with 18.1% of patients being smokers, 43.5% obese (body mass index ≥30 kg/m2) and 63.8% centrally obese (waist circumference ≥88 cm for women, ≥102 cm for men). Of patients on blood pressure lowering medication 47.0% reached the target of <140/90 mm Hg (<140/85 mm Hg in people with diabetes). Among treated dyslipidaemic patients only 46.9% attained low density lipoprotein-cholesterol target of <2.6 mmol/l. Among people treated for type 2 diabetes mellitus, 65.2% achieved the HbA1c target of <7.0%. CONCLUSION: The primary care arm of the EUROASPIRE V survey revealed that large proportions of people at high cardiovascular disease risk have unhealthy lifestyles and inadequate control of blood pressure, lipids and diabetes. Thus, the potential to reduce the risk of future cardiovascular disease throughout Europe by improved preventive cardiology programmes is substantial.

1 Department of Cardiology Interventional Electro cardiology and Hypertension Jagiellonian University Medical College Poland

Cardiovascular Medicine Department Assiut University Egypt

Center for Cardiovascular Prevention Charles University Prague Czech Republic

Centre of Cardiology and Angiology Vilnius University Hospital Santaros Klinikos Lithuania

Clinic of Cardiac and Vascular Diseases Vilnius University Lithuania

Clinic of Social and Family Medicine University of Crete Greece

Clinica de Recuperare Cardiovasculara Universitatea de Medicina si Farmacie Victor Babes Romania

Department of Cardiology National Heart Hospital Bulgaria

Department of Medicine Lausanne University Hospital Switzerland

Department of Medicine Solna Karolinska Institutet Sweden

Department of Public Health and Primary Care Ghent University Belgium

EURObservational Research Programme European Society of Cardiology France

Faculty of Medicine University of Banja Luka Bosnia and Herzegovina

Health Research Institute Al Farabi Kazakh National University Kazakhstan

Hospital Santa Cruz Centro Hospitalar de Lisboa Ocidental Portugal

Hospital Santa Marta Centro Hospitalar de Lisboa Central Portugal

Julius Center for Health Sciences and Primary Care University Medical Center Utrecht The Netherlands

Kyrgyz State Medical Academy Kyrgyzstan

Maria Cecilia Hospital GVMCare and Research Cotignola Italy

Medical Faculty University of Sarajevo Bosnia and Herzegovina

National Center of Cardiology and Internal Medicine named after academician Mirrakhimov MM Kyrgyzstan

National Institute for Prevention and Cardiovascular Health National University of Ireland Galway Republic of Ireland

National Medical Research Center of Cardiology Ministry of Healthcare of the Russian Federation Russia

National Research Center for Preventive Medicine Russia

School of Medicine University of Zagreb Croatia

St Mary's Hospital Imperial College Healthcare NHS Trust London UK

Supyk National Medical Academy of Postgraduate Education Ukraine

University Hospital Centre Zagreb University of Zagreb Croatia

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22004359
003      
CZ-PrNML
005      
20220127145322.0
007      
ta
008      
220113s2021 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1177/2047487320908698 $2 doi
035    __
$a (PubMed)33966079
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Kotseva, Kornelia $u St Mary's Hospital, Imperial College Healthcare NHS Trust, London, UK $u National Institute for Prevention and Cardiovascular Health, National University of Ireland-Galway, Republic of Ireland
245    10
$a Primary prevention efforts are poorly developed in people at high cardiovascular risk: A report from the European Society of Cardiology EURObservational Research Programme EUROASPIRE V survey in 16 European countries / $c K. Kotseva, G. De Backer, D. De Bacquer, L. Rydén, A. Hoes, D. Grobbee, A. Maggioni, P. Marques-Vidal, C. Jennings, A. Abreu, C. Aguiar, J. Badariene, J. Bruthans, R. Cifkova, K. Davletov, M. Dilic, M. Dolzhenko, D. Gaita, N. Gotcheva, H. Hasan-Ali, P. Jankowski, C. Lionis, S. Mancas, D. Milićić, E. Mirrakhimov, R. Oganov, N. Pogosova, Ž. Reiner, D. Vulić, D. Wood, EUROASPIRE V Investigators
520    9_
$a BACKGROUND: European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EUROASPIRE) V in primary care was carried out by the European Society of Cardiology EURObservational Research Programme in 2016-2018. The main objective was to determine whether the 2016 Joint European Societies' guidelines on cardiovascular disease prevention in people at high cardiovascular risk have been implemented in clinical practice. METHODS: The method used was a cross-stional survey in 78 centres from 16 European countries. Patients without a history of atherosclerotic cardiovascular disease either started on blood pressure and/or lipid and/or glucose lowering treatments were identified and interviewed ≥ 6 months after the start of medication. RESULTS: A total of 3562 medical records were reviewed and 2759 patients (57.6% women; mean age 59.0 ± 11.6 years) interviewed (interview rate 70.0%). The risk factor control was poor with 18.1% of patients being smokers, 43.5% obese (body mass index ≥30 kg/m2) and 63.8% centrally obese (waist circumference ≥88 cm for women, ≥102 cm for men). Of patients on blood pressure lowering medication 47.0% reached the target of <140/90 mm Hg (<140/85 mm Hg in people with diabetes). Among treated dyslipidaemic patients only 46.9% attained low density lipoprotein-cholesterol target of <2.6 mmol/l. Among people treated for type 2 diabetes mellitus, 65.2% achieved the HbA1c target of <7.0%. CONCLUSION: The primary care arm of the EUROASPIRE V survey revealed that large proportions of people at high cardiovascular disease risk have unhealthy lifestyles and inadequate control of blood pressure, lipids and diabetes. Thus, the potential to reduce the risk of future cardiovascular disease throughout Europe by improved preventive cardiology programmes is substantial.
650    _2
$a senioři $7 D000368
650    12
$a kardiologie $7 D002309
650    12
$a kardiovaskulární nemoci $x diagnóza $x epidemiologie $x prevence a kontrola $7 D002318
650    12
$a diabetes mellitus 2. typu $7 D003924
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a rizikové faktory kardiovaskulárních chorob $7 D000082742
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a primární prevence $7 D011322
650    _2
$a rizikové faktory $7 D012307
651    _2
$a Evropa $x epidemiologie $7 D005060
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a De Backer, Guy $u National Institute for Prevention and Cardiovascular Health, National University of Ireland-Galway, Republic of Ireland
700    1_
$a De Bacquer, Dirk $u Department of Public Health and Primary Care, Ghent University, Belgium
700    1_
$a Rydén, Lars $u Department of Medicine Solna, Karolinska Institutet, Sweden
700    1_
$a Hoes, Arno $u Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, The Netherlands
700    1_
$a Grobbee, Diederick $u Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, The Netherlands
700    1_
$a Maggioni, Aldo $u Maria Cecilia Hospital, GVMCare & Research Cotignola, Italy $u EURObservational Research Programme, European Society of Cardiology, France
700    1_
$a Marques-Vidal, Pedro $u Department of Medicine, Lausanne University Hospital, Switzerland
700    1_
$a Jennings, Catriona $u National Institute for Prevention and Cardiovascular Health, National University of Ireland-Galway, Republic of Ireland
700    1_
$a Abreu, Ana $u Hospital Santa Marta, Centro Hospitalar de Lisboa Central, Portugal
700    1_
$a Aguiar, Carlos $u Hospital Santa Cruz, Centro Hospitalar de Lisboa Ocidental, Portugal
700    1_
$a Badariene, Jolita $u Clinic of Cardiac and Vascular Diseases, Vilnius University, Lithuania $u Centre of Cardiology and Angiology, Vilnius University Hospital Santaros Klinikos, Lithuania
700    1_
$a Bruthans, Jan $u Center for Cardiovascular Prevention, Charles University in Prague, Czech Republic
700    1_
$a Cifkova, Renata $u Center for Cardiovascular Prevention, Charles University in Prague, Czech Republic
700    1_
$a Davletov, Kairat $u Health Research Institute, Al-Farabi Kazakh National University, Kazakhstan
700    1_
$a Dilic, Mirza $u Medical Faculty, University of Sarajevo, Bosnia and Herzegovina
700    1_
$a Dolzhenko, Maryna $u Supyk National Medical Academy of Postgraduate Education, Ukraine
700    1_
$a Gaita, Dan $u Clinica de Recuperare Cardiovasculara, Universitatea de Medicina si Farmacie Victor Babes, Romania
700    1_
$a Gotcheva, Nina $u Department of Cardiology, National Heart Hospital, Bulgaria
700    1_
$a Hasan-Ali, Hosam $u Cardiovascular Medicine Department, Assiut University, Egypt
700    1_
$a Jankowski, Piotr $u I Department of Cardiology, Interventional Electro-cardiology and Hypertension, Jagiellonian University Medical College, Poland
700    1_
$a Lionis, Christos $u Clinic of Social and Family Medicine, University of Crete, Greece
700    1_
$a Mancas, Silvia $u Clinica de Recuperare Cardiovasculara, Universitatea de Medicina si Farmacie Victor Babes, Romania
700    1_
$a Milićić, Davor $u School of Medicine, University of Zagreb, Croatia
700    1_
$a Mirrakhimov, Erkin $u Kyrgyz State Medical Academy, Kyrgyzstan $u National Center of Cardiology and Internal Medicine named after academician Mirrakhimov MM, Kyrgyzstan
700    1_
$a Oganov, Rafael $u National Research Center for Preventive Medicine, Russia
700    1_
$a Pogosova, Nana $u National Medical Research Center of Cardiology, Ministry of Healthcare of the Russian Federation, Russia
700    1_
$a Reiner, Željko $u University Hospital Centre Zagreb, University of Zagreb, Croatia
700    1_
$a Vulić, Duško $u Faculty of Medicine, University of Banja Luka, Bosnia and Herzegovina
700    1_
$a Wood, David $u National Institute for Prevention and Cardiovascular Health, National University of Ireland-Galway, Republic of Ireland
710    2_
$a EUROASPIRE V Investigators
773    0_
$w MED00188754 $t European journal of preventive cardiology $x 2047-4881 $g Roč. 28, č. 4 (2021), s. 370-379
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33966079 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220113 $b ABA008
991    __
$a 20220127145318 $b ABA008
999    __
$a ok $b bmc $g 1751728 $s 1155508
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 28 $c 4 $d 370-379 $e 20210508 $i 2047-4881 $m European journal of preventive cardiology $n Eur J Prev Cardiol $x MED00188754
LZP    __
$a Pubmed-20220113

Najít záznam

Citační ukazatele

Možnosti archivace